uploads///Spin off

Philip Morris’s Spin-off from Altria, with New Collaborations

By

Sep. 12 2015, Updated 3:06 p.m. ET

The spin-off

On March 2008, Philip Morris International (PM) split from its parent company, Altria Group (MO). Prior to the spin-off, Philip Morris was a wholly owned subsidiary of Altria, until Altria distributed all its shares in the subsidiary company. As part of the spin-off agreement, Altria still sells Marlboro exclusively in the US, while Philip Morris sells Marlboro internationally.

Article continues below advertisement

Collaborations and agreements

After the spin-off, in 2013, both companies began to collaborate, combining their marketing powers to revamp the distribution of their e-vapor products. Under this strategic framework, Philip Morris is exclusively licensed to commercialize Altria’s MarkTen e-cigarettes internationally, while Altria is exclusively licensed to commercialize two of Philip Morris’s RRPs (reduced-risk products) in the US. (To learn more about RRPs, read Part 10 of this series.)

The agreement between Altria and Philip Morris also requires both companies to cooperate mutually with FDA (Food and Drug Administration) regulatory engagements related to heated tobacco products, as well as with international regulatory authorities related to e-vapor products.

In the remainder of 2015, Philip Morris plans its own foray into the e-cigarette business. Other companies like Reynolds American (RAI), British American Tobacco (BTI), and Imperial Tobacco Group (ITYBY)—which produce VUSE, Vype, and blu eCigs, respectively—already have a growing presence in the e-cigarette market, due to the threat of declining volumes of traditional cigarettes. (Imperial Tobacco recently acquired blu eCigs from Lorillard Tobacco Company in Reynolds American’s acquisition deal with the latter company).

Expanding collaboration

More recently, following a spree of acquisitions from peer companies, Altria and Philip Morris have expanded their e-vapor development deal to include joint research, development, and a technology-sharing framework for unconventional cigarettes. This expanded agreement includes exclusive technology cross-licenses, technical information sharing, scientific assessment cooperation, regulatory engagement, and approvals related to these products.

Philip Morris has exposure in the iShares S&P 100 ETF (OEF), with 1.1% of the portfolio’s total weight.

Advertisement

More From Market Realist

  • BioNano Genomics Saphyr system
    Company & Industry Overviews
    BioNano Genomics (BNGO) Stock Looks Like a Buy, Solid Opportunity
  • Delta aircraft
    Company & Industry Overviews
    Delta Air Lines Updates Mandatory Vaccine Policy, Explained
  • AMC advertisement in walkway
    Company & Industry Overviews
    Why It's Time for Most Investors to Sell AMC Entertainment Stock
  • 100 Thieves founder Matthew Haag
    Company & Industry Overviews
    Why Growing Esports Company 100 Thieves Isn't Publicly Traded
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.